Ambrx Biopharma
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Ambrx Biopharma's balance sheet done over the years? Its assets were worth $146,977,000 last year, which is less than in the previous period. 20% of Ambrx Biopharma’s total assets is currently financed by debt. Its liabilities reached the amount of $29,127,000, which means an decrease by -25% compared compared to last year.

Debt to Assets

Ambrx Biopharma Inc. (NYSE:AMAM): Debt to assets
2019 61727000 25.74M 41.7%
2020 134021000 272.16M 203.08%
2021 229019000 39.05M 17.05%
2022 146977000 29.12M 19.82%

AMAM Balance Sheet (2019 – 2022)

2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
55.61M170.06M90.46M15.49M
Short term investments
28.87M000
Net receivables
2.05M1.34M982K1.39M
Inventory
3.73M5.16M1.44M1.12M
Other current assets
319K230K191K146K
Total current assets
90.58M176.80M93.07M18.15M
Non-current assets:
Property, Plant and Equipment
14.01M15.72M3.49M4.97M
Goodwill
0000
Intangible assets
25.25M35.96M36.82M38.28M
Long term investments
16.79M000
Other non-current assets
339K530K624K319K
Total non-current assets
56.39M52.21M40.94M43.57M
Total assets
146.97M229.01M134.02M61.72M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
407K4.26M6.47M4.21M
Short term debt
1.73M915K1.59M1.45M
Total current liabilities
16.66M24.57M13.26M14.94M
Non-current liabilities:
Long term debt
10.24M12.21M1.59M3.19M
Deferred tax
0000
Other non-current liabilities
00253.16M0
Total non-current liabilities
12.46M14.47M258.90M10.79M
Total liabilities
29.12M39.05M272.16M25.74M
Data sourceData source